Inhibition of MMP-3 activity and invasion of the MDA-MB-231 human invasive breast carcinoma cell line by bioflavonoids

Acta Pharmacologica Sinica

Volumn 30, Issue 8, 2009, Pages 1169-1176

  Phromnoi, Kanokkarn ^a   Yodkeeree, Supachai ^a   Anuchapreeda, Songyot ^b   Limtrakul, Pornngarm ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Casein zymography; Flavonoids; Invasion; Matrix metalloproteinase 3 (MMP 3); MDA MB 231 breast cancer cell

Indexed keywords

BIOFLAVONOID; CASEIN; DAIDZEIN; GENISTIN; KAEMPFEROL; MATRIX METALLOPROTEINASE 3 INHIBITOR; MATRIX METALLOPROTEINASE INHIBITOR; QUERCETIN; STROMELYSIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INVASION; CELL STRAIN MDA MB 231; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; HUMAN; HUMAN CELL; WESTERN BLOTTING; ZYMOGRAPHY;

BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; FEMALE; FLAVONOIDS; HUMANS; MATRIX METALLOPROTEINASE 3; NEOPLASM INVASIVENESS;

EID: 68349110545     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2009.107     Document Type: Article

References (43)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
2. Liu J, Zhang X, Yang F, Li T, Wei D, Ren Y. Antimetastatic effect of a lipophilic ascorbic acid derivative with antioxidation through inhibition of tumor invasion. Cancer Chemother Pharmacol 2006; 57: 584-590 (Pubitemid 43237842)
3. Curran S, Murray GI. Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 1999; 189: 300-308 (Pubitemid 29489213)
4. De CY, Szpirer C, Aly MS, Cassiman JJ, Eeckhout Y, Rousseau G. The gene for tissue inhibitor of metalloproteinases-2 is localized on human chromosome arm 17q25. Genomics 1992; 14: 782-784
5. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996; 3: 895-904.
6. Westermarck J, Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999; 13: 781-792 (Pubitemid 29220691)
7. Denys H, De WO, Nusgens B, Kong Y, Sciot R, Le AT, et al. Invasion and MMP expression profile in desmoid tumours. Br J Cancer 2004; 90: 1443-1449 (Pubitemid 38590640)
8. Sriplung H, Wiangnon S, Sontipong S, Sumitsawan Y, Martin N. Cancer incidence trends in Thailand, 1989-2000. Asian Pac J Cancer Prev 2006; 7: 239-244
9. Balduyck M, Zerimech F, Gouyer V, Lemaire R, Hemon B, Grard G, et al. Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin Exp Metastasis 2000; 18: 171-178
10. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 1999; 274: 13066-13076 (Pubitemid 129518506)
11. Hotary K, Li XY, Allen E, Stevens SL, Weiss SJ. A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev 2006; 20: 2673-2686 (Pubitemid 44498378)
12. Murphy GJ, Murphy G, Reynolds JJ. The origin of matrix metalloproteinases and their familial relationships. FEBS Lett 1991; 289: 4-7.
13. Wu JJ, Lark MW, Chun LE, Eyre DR. Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J Biol Chem 1991; 266: 5625-5628
14. Siri A, Knauper V, Veirana N, Caocci F, Murphy G, Zardi L. Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem 1995; 270: 8650-8654
15. Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H. Immuno localization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis 1989; 48: 645-653 (Pubitemid 19201961)
16. Firestein GS, Paine MM, Littman BH. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum 1991; 34: 1094-1105
17. Kleiner DE Jr, Stetler-Stevenson WG. Structural biochemistry and activation of matrix metalloproteases. Curr Opin Cell Biol 1993; 5: 891-897
18. Hegedus L, Cho H, Xie X, Eliceiri GL. Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness. J Cell Physiol 2008; 216: 480-485 (Pubitemid 351898476)
19. Heikkil P, Teronen O, Moilanen M, Konttinen YT, Hanemaaijer R, Laitinen M, et al. Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines. Anti-Cancer Drugs 2002; 13: 245-254 (Pubitemid 34492706)
20. Mercapide J, Lopez De Cicco R, Castresana JS, Klein-Szanto AJ. Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines. Int J Cancer 2003; 106: 676-682 (Pubitemid 36993390)
21. Yodkeeree S, Chaiwangyen W, Garbisa S, Limtrakul P. Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA. J Nutr Biochem 2009; 20: 87-95.
22. Heim KE, Tagliaferro AR, Bobilya DJ. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem 2002; 13: 572-584
23. Shun FY, Wen EY, Wu HK, Horng RC, Shu CC, Yih SH. Antimetastatic potentials of flavones on oral cancer cell via an inhibition of matrix-degrading proteases. Arch Oral Biol 2008; 53: 287-294
24. Lim H, Kim HP. Inhibition of mammalian collagenase, matrix metalloproteinase-1, by naturally-occurring flavonoids. Planta Med 2007; 73: 1267-1274 (Pubitemid 350004832)
25. Lin CW, Hou WC, Shen SC, Juan SH, Ko CH, Wang LM, et al. Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 2008; 29: 1807-1815
26. Vijayababu MR, Arunkumar A, Kanagaraj P, Venkataraman P, Krishnamoorthy G, Arunakaran J. Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3). Mol Cell Biochem 2006; 287: 109-116 (Pubitemid 44057398)
27. Caltagirone S, Rossi C, Poggi A, Ranelletti FO, Natali PG, Brunetti M, et al. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer 2000; 87: 595-600. (Pubitemid 30639822)
28. Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Toxicol Appl Pharmacol 2008; 226: 178-191
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63. (Pubitemid 14203433)
30. Dona M, Dell'Aica I, Pezzato E, Sartor L, Calabrese F, Della BM, et al. Hyperforin inhibits cancer invasion and metastasis. Cancer Res 2004; 64: 6225-6232 (Pubitemid 39129424)
31. Airola K, Reunala T, Salo S, Saarialho-Kere UK. Urokinase plasminogen activator is expressed by basal keratinocytes before interstitial collagenase, stromelysin-1, and laminin-5 in experimentally induced dermatitis herpetiformis lesions. J Invest Dermatol 1997; 108: 7-11. (Pubitemid 27019835)
32. Martin MD, Matrisian LM. The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Rev 2007; 26: 717-724
33. Van Themsche C, Potworowski EF, St-Pierre Y. Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo. Biochem Biophys Res Commun 2004; 315: 884-891
34. Juncker-Jensen A, Romer J, Pennington CJ, Lund LR, Almholt K. Spontaneous metastasis in matrix metalloproteinase 3-deficient mice. Mol Carcinog 2009; 48: 618-625
35. Haddad AQ, Venkateswaran V, Viswanathan L, Teahan SJ, Fleshner NE, Klotz LH. Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines. Prostate Cancer Prostatic Dis 2006; 9: 68-76. (Pubitemid 43378873)
36. Farina HG, Pomies M, Alonso DF, Gomez DE. Antitumor and antiangio genic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol Rep 2006; 16: 885-891
37. Zhang XM, Huang SP, Xu Q. Quercetin inhibits the invasion of murine melanoma B16-BL6 cells by decreasing pro-MMP-9 via the PKC pathway. Cancer Chemother Pharmacol 2004; 53: 82-88 (Pubitemid 38161193)
38. Rowell C, Carpenter DM, Lamartiniere CA. Chemoprevention of breast cancer, proteomic discovery of genistein action in the rat mammary gland. J Nutr 2005; 135: 2953S-2959S. (Pubitemid 43156572)
39. Magee PJ, McGlynn H, Rowland IR. Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro. Cancer Lett 2004; 208: 35-41.
40. Kousidou OC, Mitropoulou TN, Roussidis AE, Kletsas D, Theocharis AD, Karamanos NK. Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors. Int J Oncol 2005; 26: 1101-1109
41. Magee PJ, McGlynn H, Rowland IR. Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro. Cancer Lett 2004; 208: 35-41.
42. Rasmussen HS, McCann PP. Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat. Pharmacol Ther 1997; 75: 69-75.
43. Baba Y, Tsukuda M, Mochimatsu I, Furukawa S, Kagata H, Nagashima Y, et al. Inostamycin, an inhibitor of cytidine 5′-diphosphate 1,2-diacylsn- glycerol (CDP-DG): inositol transferase, suppresses invasion ability by reducing productions of matrix metalloproteinase-2 and -9 and cell motility in HSC-4 tongue carcinoma cell line. Clin Exp Metastasis 2000; 18: 273-279 (Pubitemid 32269997)